Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zambetti

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|December 1, 1991
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapyG Bonadonna, P Valagussa, C Brambilla, et al.
Breast Cancer Research and Treatment|May 1, 1990
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyP Valagussa, M Zambetti, G Bonadonna, et al.
Seminars in Oncology|March 20, 2001
Adjuvant and neoadjuvant treatment of breast cancerL Gianni, P Valagussa, M Zambetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancerP Valagussa, M Zambetti, S Biasi, et al.
Breast Cancer Research and Treatment|October 4, 2000
Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxelM Zambetti, G Mariani, R Demicheli, et al.
The American Journal of Medicine|September 1, 1987
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicityR B Weiss, P Valagussa, A Moliterni, et al.
American Journal of Clinical Oncology|April 1, 1989
First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma. A preliminary reportM Zambetti, L Gianni, A Escobedo, et al.
Breast Cancer Research and Treatment|January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerG Bonadonna, P Valagussa, A Rossi, et al.
American Journal of Clinical Oncology|February 1, 1996
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot studyM Zambetti, M Terenziani, C Bartoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer InstituteG Bonadonna, P Valagussa, C Brambilla, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|December 1, 1991
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapyG Bonadonna, P Valagussa, C Brambilla, et al.
Breast Cancer Research and Treatment|May 1, 1990
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyP Valagussa, M Zambetti, G Bonadonna, et al.
Seminars in Oncology|March 20, 2001
Adjuvant and neoadjuvant treatment of breast cancerL Gianni, P Valagussa, M Zambetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancerP Valagussa, M Zambetti, S Biasi, et al.
Breast Cancer Research and Treatment|October 4, 2000
Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxelM Zambetti, G Mariani, R Demicheli, et al.
The American Journal of Medicine|September 1, 1987
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicityR B Weiss, P Valagussa, A Moliterni, et al.
American Journal of Clinical Oncology|April 1, 1989
First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma. A preliminary reportM Zambetti, L Gianni, A Escobedo, et al.
Breast Cancer Research and Treatment|January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerG Bonadonna, P Valagussa, A Rossi, et al.
American Journal of Clinical Oncology|February 1, 1996
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot studyM Zambetti, M Terenziani, C Bartoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer InstituteG Bonadonna, P Valagussa, C Brambilla, et al.
Pageof 5